Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FAN09
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,831
Award facts
- Contract value 100% obligated
- $1,831.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,831.06 to AmerisourceBergen Drug Corp on December 2, 2025, under the Pharmaceutical Prime Vendor Division contract. This firm fixed-price delivery order, with a completion date of December 3, 2025, represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively placed with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, supplying a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains.
This delivery order falls within AmerisourceBergen's broader role as a prime pharmaceutical vendor supporting military healthcare systems and other government entities including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract history demonstrates consistent capability to fulfill pharmaceutical supply requirements through competitive award processes. The DLA's Pharmaceutical Prime Vendor Global Program represents a strategic approach to medical supply chain management, with plans to establish Generation V contracts across multiple regions and contractors to ensure robust pharmaceutical support for defense and federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DU26FAN09?
SPE2DU26FAN09 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DU26FAN09 worth?
The government has obligated $1,831 on SPE2DU26FAN09.
Is contract SPE2DU26FAN09 an order under another contract?
Yes. SPE2DU26FAN09 is a delivery order under SPE2DU25D3406, an indefinite delivery contract.
Was contract SPE2DU26FAN09 competed?
The extent of competition for SPE2DU26FAN09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award